Shirai M, Vacchio M S, Hodes R J, Berzofsky J A
Molecular Immunogenetics and Vaccine Research Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
J Immunol. 1993 Aug 15;151(4):2283-95.
The T cell response to HIV-1 gp160 is among the most thoroughly studied immune responses to HIV-1 products. In our previous work, the MHC class I molecule Dd as well as H-2u, p, and q, were found to present P18 and HP53, two determinants of HIV-1 gp160, to CD8+ CTL in mice. We have studied the TCR V beta chain expression in CTL lines, either cross-reactive for these two peptides or specific for P18 alone, in these four different MHC haplotypes. The usage of V beta in T cells showing cross-reaction between these two peptides was remarkably conserved (primarily V beta 8 family, with some use of V beta 14) despite the extensive TCR V beta diversity of the non-cross-reactive CTL, which did not use V beta 8 or 14. This correlation of V beta usage with fine specificity was consistent in H-2d, u, and p (p < 0.01), but not in H-2q. The correlation of V beta use with peptide fine specificity independent of MHC restriction was unexpected. The strong predominance of V beta 8 family TCR was all the more surprising in view of the finding that mice bearing a genomic deletion of V beta 8 can still produce T cells with the cross-reactive phenotype, implying that other V beta chains can produce this specificity. We therefore asked whether the complexes of P18 with H-2d, p, and u are recognized as identical, and observed the surprising result that H-2d, p, and u cells mutually cross-present the peptides P18 and HP53 to allogeneic CTL lines and individual clones of each of the other haplotypes, whereas none of these cross-present to H-2q CTL, nor do H-2q targets present to CTL of the other haplotypes. This degeneracy of MHC restriction is novel for class I molecules. Moreover, the observed restriction in V beta usage occurs only in the unique set of CTL that exhibit both peptide-cross-reactive fine specificity and MHC allogeneic cross-presentation. The observation that a strain of mice in which the V beta 8 family is genomically deleted can still make CTL of this phenotype using another V beta demonstrates the plasticity of the class I MHC-restricted repertoire when the dominating receptor is not available.
T细胞对HIV-1 gp160的反应是对HIV-1产物研究最为深入的免疫反应之一。在我们之前的研究中,发现MHC I类分子Dd以及H-2u、p和q,能将HIV-1 gp160的两个决定簇P18和HP53呈递给小鼠体内的CD8⁺CTL。我们研究了在这四种不同MHC单倍型中,对这两种肽具有交叉反应性或仅对P18特异的CTL系中TCR Vβ链的表达情况。尽管非交叉反应性CTL的TCR Vβ具有广泛的多样性(不使用Vβ8或14),但在对这两种肽表现出交叉反应的T细胞中,Vβ的使用却显著保守(主要是Vβ8家族,少量使用Vβ14)。Vβ使用与精细特异性之间的这种相关性在H-2d、u和p中是一致的(p<0.01),但在H-2q中并非如此。Vβ使用与肽精细特异性之间的相关性独立于MHC限制,这一现象出乎意料。鉴于携带Vβ8基因缺失的小鼠仍能产生具有交叉反应表型的T细胞这一发现,Vβ8家族TCR的强烈优势就更加令人惊讶,这意味着其他Vβ链也能产生这种特异性。因此,我们询问P18与H-2d、p和u形成的复合物是否被识别为相同,并观察到了令人惊讶的结果:H-2d、p和u细胞能将肽P18和HP53相互交叉呈递给其他单倍型的同种异体CTL系和单个克隆,而这些细胞均不能交叉呈递给H-2q CTL,H-2q靶细胞也不能呈递给其他单倍型的CTL。MHC限制的这种简并性对于I类分子来说是新颖的。此外,观察到的Vβ使用限制仅发生在同时表现出肽交叉反应性精细特异性和MHC同种异体交叉呈递的独特CTL组中。携带Vβ8家族基因缺失的小鼠品系仍能使用另一种Vβ产生这种表型的CTL,这一观察结果表明,当主要受体不可用时,I类MHC限制的库具有可塑性。